When re-investigating some of these breast cancer patients from whom we had immunohistochemical analysis of HER2 expression from the cancer tissue removed during surgery, we found that in four patients who fell into the high probability group but were initially diagnosed as HER2neg from biopsy material, the surgically removed tumours stained positive for HER2. This evidence concerns the gene ERBB2 and neoplasm.